|
|
|
Volumn 23, Issue 6 SUPPL. 13, 1996, Pages 1-7
|
|
Etoposide phosphate: What, why, where, and how?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLEOMYCIN;
CISPLATIN;
CYTARABINE;
DOXORUBICIN;
ETOPOFOS;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
IFOSFAMIDE;
MESNA;
MITOPODOZIDE;
PODOPHYLLOTOXIN DERIVATIVE;
PREDNISONE;
TENIPOSIDE;
VINBLASTINE;
VINCRISTINE;
ANTINEOPLASTIC ACTIVITY;
CHEMICAL MODIFICATION;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
DOSE CALCULATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG MEGADOSE;
HUMAN;
LUNG NON SMALL CELL CANCER;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
ANTINEOPLASTIC AGENTS;
CARCINOMA, SMALL CELL;
CLINICAL TRIALS;
ETOPOSIDE;
HUMANS;
LUNG NEOPLASMS;
ORGANOPHOSPHORUS COMPOUNDS;
PODOPHYLLOTOXIN;
|
|
EID: 0030477322
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (94)
|
|
References (27)
|
